Researchers led by Dr. Alex Lehrer at the University of Hawaii (UH) medical school have successfully developed a vaccine candidate for the Zika virus, showing that it is effective in protecting both mice and now monkeys from the infection.
Dr. Lehrer thinks the vaccine his team proposes might be safer that other candidate vaccines, especially keeping in mind that pregnant women constitute a significant part of the target population for a Zika vaccine.
Demonstrating the effectiveness of the vaccine candidate in monkeys (non-human primates) is an important milestone because it typically predicts the vaccine will work in humans, enabling further clinical development.
A strong global initiative to battle Zika has produced more than 30 vaccine candidates since outbreaks in 2015-2016 in Brazil linked the infection in some pregnant women to severe birth defects in their newborns. Zika is spread by the bite of infected mosquitos and through sex.
The proposed vaccine reported by scientists at the UH John A. Burns School of Medicine (JABSOM) in the journals Frontiers in Immunologyand mSphere, an open access journal of the American Society for Microbiology, is a recombinant subunit vaccine that uses only a small part (protein) of the Zika virus, produced in insect cells.
“We believe our vaccine candidate shows much promise particularly as it showed to require only two immunizations given three weeks apart and is a potentially safer alternative to other candidates already in clinical trials,” said Dr. Axel Lehrer, JABSOM (Assistant) Professor of Tropical Medicine and Infectious Disease.
Lehrer thinks the vaccine his team proposes might be safer that other candidate vaccines, especially keeping in mind that pregnant women constitute a significant part of the target population for a Zika vaccine.
The research team at JABSOM included two senior graduate students who served as lead authors of the scientific research papers. Liana Medina, whose early training was directly supported by a National Institutes of Health Diversity in Health-Related Research grant, and Honolulu native Albert To are the graduate student lead authors.
Honolulu-based Hawai’i Biotech is a key partner in the vaccine development project with UH. Two of their scientists, Dr. Jaime Horton and David Clements, contributed to the most recent publication demonstrating vaccine efficacy in monkeys, along with collaborators from Bioqual Inc. of Rockville, Maryland, and the Department of Diagnostic Medicine/Pathobiology, Biosecurity Research Institute, College of Veterinary Medicine, at Kansas State University.
“The intense search for a Zika remedy since early 2016 has required us to be agile, and we believe our vaccine candidate research demonstrates that such quick-turnaround results can be achieved in academic and scientific partnerships here in Hawai’i,” said Dr. Lehrer. “It is incredibly gratifying that two of the scientists we are training to be the future of biomedical science played key roles in gathering, analyzing and reporting their conclusions. We hope Hawai’i’s citizens find that as inspiring as we do.”
Graduate student scientist and research co-author Liana Medina said there were chances to develop new skills at every step along the way. “Having the opportunity to see the vaccine’s development from its very first stages as Zika E protein being produced by Dr. Kenji Obadia, at the time also a student in our department, to a vaccine that is efficacious and safe in animal models was a unique learning experience. Being a part of the process allowed me grow as a student in this field,” said Medina.
Fellow graduate student and co-author Albert To said the team’s results “put us on the world-stage and highlight the talent we have here in Hawai?i.” He said, “Being involved with this project has given me a glimpse of the type of research and results needed to progress an idea to a potential preventative therapy used by thousands of people worldwide.”
The Latest on: Zika virus
via Google News
The Latest on: Zika virus
- Zika Virus Market Size, Historical Growth, Analysis, Opportunities and Forecast To 2024 on April 17, 2019 at 3:35 am
Apr 17, 2019 (Heraldkeeper via COMTEX) -- Market Study Report LLC adds Global Zika Virus market research providing newest industry data and covering future trends, allowing you to identify the ... […]
- Brazilian Researchers Develop Faster Test to Detect Zika Virus on April 15, 2019 at 6:38 am
BRASILIA, BRAZIL – A cheaper and faster test for detecting the Zika virus is being developed by Fiocruz (Oswaldo Cruz Foundation) in Pernambuco, Brazil. The researchers are hopeful that the new test ... […]
- If Rio Olympics Were Today, USWNT GK Hope Solo Would Skip Due To Zika Virus Concern on April 12, 2019 at 4:59 pm
After a win over Costa Rica Wednesday in Frisco, U.S. Women's National Soccer goalkeeper Hope Solo said she would skip the Rio 2016 Olympics if she had to make the choice today out of concern for the ... […]
- Exscalate Platform Addresses Zika Epidemic on April 11, 2019 at 9:32 pm
The EXSCALATE platform’s first test field is the epidemiological crisis caused by the Zika virus, which to date is still lacking effective treatment. In this case EXSCALATE has identified molecules ... […]
- Zika Virus Update for Summer 2019 on April 10, 2019 at 11:21 am
With summer just around the corner is St. Louis, many people are planning their BBQs, picnics, and relaxing days enjoying the sunshine. But as the weather warms up, pests will begin to emerge from ... […]
- Molecules with strong anti-Zika potential created by researchers on April 8, 2019 at 4:07 am
A new study published in the Journal of Medicinal Chemistry details a promising method for treating the Zika virus. Transmitted by the Aedes mosquito, the Zika virus has become a worldwide health ... […]
- Turks & Caicos Declared Zika Free on April 5, 2019 at 3:50 pm
In a statement in October of 2018, the Caribbean Public Health Agency (CARPHA) noted that “the Zika virus transmission in the Caribbean had been interrupted for over 12 months, or was at undetectable ... […]
- Synthetic antibody rapidly protects mice and monkeys from Zika on April 5, 2019 at 2:31 pm
"The DMAb-ZK190 studies are the first demonstration of Zika virus infection control using a synthetic nucleic acid approach for antibody gene delivery," says senior study author David Weiner ... […]
- Molecules with strong anti-Zika virus potential on April 4, 2019 at 10:29 am
Scientists have created a molecule with both strong anti-Zika properties and low toxicity to animal cells. The Zika virus is widely known for causing microcephaly and other brain defects in the ... […]
via Bing News